# Specification Quality Checklist: Group Dependencies & Product Health

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-10-18
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- All scope decisions are already ratified: ADR-110 (+ 2026-10-18 bulk
  amendment), ADR-112, and the improvement-plan addendum — no
  [NEEDS CLARIFICATION] markers were needed.
- Endpoint/route names and field shapes appear in FRs only where the ratified
  ADRs fix them as contract (union input on `POST /products/{id}/depends-on`,
  target-kind discriminator on remove, `health` response shape,
  `toEntityType: component_group`). This matches house style (spec 018 cites
  `409 CYCLE_DETECTED`) — the spec still prescribes *what*, not *how*.
- Judgment call encoded as an explicit edge case + assumption: "direct"
  health sources per ADR-112 exclude `COMPOSES`-inherited dependencies
  (no-double-reporting rationale). If reviewers disagree, resolve at
  `/speckit-clarify` or `/speckit-plan`.
